Modelling sex differences of neurological disorders in vitro
Source abstract
Abstract
Although in vitro models are valuable tools for modelling neurological disorders such as neurodegenerative diseases and neuropsychiatric disorders, it remains unclear whether and how biological sex characteristics should be considered when designing experiments. The historical failure to incorporate sex as a biological variable and acknowledge sex and gender differences in preclinical and clinical research has created a translation gap, which is only now beginning to be addressed. Sex effects are observed across mechanisms in common neuropsychiatric and neurodegenerative disorders. Therefore, it is imperative to incorporate sex differences into both in vitro and in vivo models to develop more precise and sustainable research tools for brain disorders. Such an approach will enable researchers to account for the physiological and pathological characteristics of male and female brains, improving the replicability and translatability of research results. In this Review, we discuss in vitro models of increasing complexity used for exploring pathological mechanisms and pharmacological target development. We address the advantages and challenges of using in vitro models to investigate sex differences in neurological disorders, starting with the types of cells used in in vitro models, including immortalized cell lines, primary cultures, induced pluripotent stem cells, up to 3D organoid and organ-on-a-chip models. Furthermore, we propose a roadmap and discussion of best practices to incorporate sex as a biological variable into in vitro models of neurodegenerative diseases and neuropsychiatric disorders.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Sex and Gender in Healthcare · Health Systems, Economic Evaluations, Quality of Life · Science, Research, and Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. DuMont, M. et al. Sex representation in neurodegenerative and psychiatric disorders’ preclinical and clinical studies. Neurobiol. Dis. 184, 106214 (2023).10.1016/j.nbd.2023.106214 ↗
2. Feigin, V. L. et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 19, 255–265 (2020).10.1016/S1474-4422(19)30411-9 ↗
3. Kaczkurkin, A. N., Raznahan, A. & Satterthwaite, T. D. Sex differences in the developing brain: insights from multimodal neuroimaging. Neuropsychopharmacology 44, 71–85 (2019).10.1038/s41386-018-0111-z ↗
4. Eliot, L. et al. Why and how to account for sex and gender in brain and behavioral research. J. Neurosci. 43, 6344–6356 (2023).10.1523/JNEUROSCI.0020-23.2023 ↗
5. Fish, A. M. et al. Sex-biased trajectories of amygdalo-hippocampal morphology change over human development. NeuroImage 204, 116122 (2020).10.1016/j.neuroimage.2019.116122 ↗
6. Miller, D. I. & Halpern, D. F. The new science of cognitive sex differences. Trends Cogn. Sci. 18, 37–45 (2014).10.1016/j.tics.2013.10.011 ↗
7. Sundermann, E. E. et al. Does the female advantage in verbal memory contribute to underestimating Alzheimer’s disease pathology in women versus men? J. Alzheimer’s Dis. 56, 947–957 (2017).10.3233/JAD-160716 ↗
8. Li, R. & Singh, M. Sex differences in cognitive impairment and Alzheimer’s disease. Front. Neuroendocrinol. 35, 385–403 (2014).10.1016/j.yfrne.2014.01.002 ↗
9. Ferretti, M. T. et al. Sex differences in Alzheimer disease — the gateway to precision medicine. Nat. Rev. Neurol. 14, 457–469 (2018).10.1038/s41582-018-0032-9 ↗
10. Nicoletti, A. et al. Sex and gender differences in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: a narrative review. Mech. Ageing Dev. 212, 111821 (2023).10.1016/j.mad.2023.111821 ↗
11. De Souza Santos, R., Frank, A. P., Palmer, B. F. & Clegg, D. J. Sex and media: considerations for cell culture studies. ALTEX Altern. Anim. Experiment. 35, 435–440 (2018).
12. Mauvais-Jarvis, F., Arnold, A. P. & Reue, K. A guide for the design of pre-clinical studies on sex differences in metabolism. Cell Metab. 25, 1216–1230 (2017).10.1016/j.cmet.2017.04.033 ↗
13. Mayne, B. T. et al. Large scale gene expression meta-analysis reveals tissue-specific, sex-biased gene expression in humans. Front. Genet. 7, 183 (2016).10.3389/fgene.2016.00183 ↗
14. Navakkode, S. et al. Sex‐specific accelerated decay in time/activity‐dependent plasticity and associative memory in an animal model of Alzheimer’s disease. Aging Cell 20, e13502 (2021).10.1111/acel.13502 ↗
15. Hyer, M. M., Phillips, L. L. & Neigh, G. N. Sex differences in synaptic plasticity: hormones and beyond. Front. Mol. Neurosci. 11, 266 (2018).10.3389/fnmol.2018.00266 ↗
16. Been, L. E., Sheppard, P. A. S., Galea, L. A. M. & Glasper, E. R. Hormones and neuroplasticity: a lifetime of adaptive responses. Neurosci. Biobehav. Rev. 132, 679–690 (2022).10.1016/j.neubiorev.2021.11.029 ↗
17. Brown, C. M., Wong, Q., Thakur, A., Singh, K. & Singh, R. S. Origin of sex-biased mental disorders: do males and females experience different selective regimes? J. Mol. Evol. 90, 401–417 (2022).10.1007/s00239-022-10072-2 ↗
18. Kim, D.-W. et al. Multimodal analysis of cell types in a hypothalamic node controlling social behavior. Cell 179, 713–728.e17 (2019).10.1016/j.cell.2019.09.020 ↗
19. Mulvey, B. et al. Molecular and functional sex differences of noradrenergic neurons in the mouse locus coeruleus. Cell Rep. 23, 2225–2235 (2018).10.1016/j.celrep.2018.04.054 ↗
20. Giacobini, E. & Pepeu, G. Sex and gender differences in the brain cholinergic system and in the response to therapy of Alzheimer disease with cholinesterase inhibitors. Curr. Alzheimer Res. 15, 1077–1084 (2018).10.2174/1567205015666180613111504 ↗
21. Wickens, M. M., Bangasser, D. A. & Briand, L. A. Sex differences in psychiatric disease: a focus on the glutamate system. Front. Mol. Neurosci. 11, 197 (2018).10.3389/fnmol.2018.00197 ↗
22. Hanamsagar, R. & Bilbo, S. D. Sex differences in neurodevelopmental and neurodegenerative disorders: focus on microglial function and neuroinflammation during development. J. Steroid Biochem. Mol. Biol. 160, 127–133 (2016).10.1016/j.jsbmb.2015.09.039 ↗
23. Lynch, M. A. Exploring sex-related differences in microglia may be a game-changer in precision medicine. Front. Aging Neurosci. 14, 868448 (2022).10.3389/fnagi.2022.868448 ↗
24. Gamache, J., Yun, Y. & Chiba-Falek, O. Sex-dependent effect of APOE on Alzheimer’s disease and other age-related neurodegenerative disorders. Dis. Models Mech. 13, dmm045211 (2020).10.1242/dmm.045211 ↗
25. Ferretti, M. T. et al. Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice. Eur. J. Neurol. 27, 928–943 (2020).10.1111/ene.14174 ↗
26. Ferri, S. L., Abel, T. & Brodkin, E. S. Sex differences in autism spectrum disorder: a review. Curr. Psychiatry Rep. 20, 9 (2018).10.1007/s11920-018-0874-2 ↗
27. Santos, S., Ferreira, H., Martins, J., Gonçalves, J. & Castelo-Branco, M. Male sex bias in early and late onset neurodevelopmental disorders: shared aspects and differences in autism spectrum disorder, attention deficit/hyperactivity disorder, and schizophrenia. Neurosci. Biobehav. Rev. 135, 104577 (2022).10.1016/j.neubiorev.2022.104577 ↗
28. Miller, V. M. Why are sex and gender important to basic physiology and translational and individualized medicine? Am. J. Physiol. Heart Circ. Physiol. 306, H781–H788 (2014).10.1152/ajpheart.00994.2013 ↗
29. McCarthy, M. M. Multifaceted origins of sex differences in the brain. Philos. Trans. R. Soc. B Biol. Sci. 371, 20150106 (2016).10.1098/rstb.2015.0106 ↗
30. Waters, A. & Laitner, M. H. Biological sex differences in Alzheimer’s preclinical research: a call to action. Alzheimer’s Demen. Transl. Res. Clin. Interv. 7, e12111 (2021).10.1002/trc2.12111 ↗
31. Abd-Elrahman, K. S., Hamilton, A., Vasefi, M. & Ferguson, S. S. G. Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer’s disease mouse models. Mol. Brain 11, 19 (2018).10.1186/s13041-018-0364-9 ↗
32. Abd-Elrahman, K. S. et al. Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer’s disease model mice in a sex-selective manner. Sci. Signal. 13, eabd2494 (2020).10.1126/scisignal.abd2494 ↗
33. Straub, R. E. et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71, 337–348 (2002).10.1086/341750 ↗
34. Geraci, F. et al. Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT. Mol. Psychiatry 29, 2666–2677 (2024).10.1038/s41380-024-02527-3 ↗
35. Zeng, P.-Y., Tsai, Y.-H., Lee, C.-L., Ma, Y.-K. & Kuo, T.-H. Minimal influence of estrous cycle on studies of female mouse behaviors. Front. Mol. Neurosci. 16, 1146109 (2023).10.3389/fnmol.2023.1146109 ↗
36. Dalla, C. et al. Practical solutions for including sex as a biological variable (SABV) in preclinical neuropsychopharmacological research. J. Neurosci. Methods 401, 110003 (2024).10.1016/j.jneumeth.2023.110003 ↗
37. D’Amore, A., Marchese, M., Afshar-Saber, W. & Hameed, M. Q. Editorial: in vitro and in vivo models for neurodevelopmental disorders. Front. Neurosci. 17, 1239577 (2023).10.3389/fnins.2023.1239577 ↗
38. Jensen, C. & Teng, Y. Is it time to start transitioning from 2D to 3D cell culture? Front. Mol. Biosci. 7, 33 (2020).10.3389/fmolb.2020.00033 ↗
39. Pereira, I., Lopez-Martinez, M. J. & Samitier, J. Advances in current in vitro models on neurodegenerative diseases. Front. Bioeng. Biotechnol. 11, 1260397 (2023).10.3389/fbioe.2023.1260397 ↗
40. Kouthouridis, S., Robson, E., Hartung, A., Raha, S. & Zhang, B. Se(XY) matters: the importance of incorporating sex in microphysiological models. Trends Biotechnol. 40, 1284–1298 (2022).10.1016/j.tibtech.2022.04.005 ↗
41. Waltz, M., Fisher, J. A., Lyerly, A. D. & Walker, R. L. Evaluating the National Institutes of Health’s sex as a biological variable policy: conflicting accounts from the front lines of animal research. J. Womens Health 30, 348–354 (2021).10.1089/jwh.2020.8674 ↗
42. Park, M.-N., Park, J. H., Paik, H. Y. & Lee, S. K. Insufficient sex description of cells supplied by commercial vendors. Am. J. Physiol. Cell Physiol. 308, C578–C580 (2015).10.1152/ajpcell.00396.2014 ↗
43. Butlen-Ducuing, F. et al. Implications of sex-related differences in central nervous system disorders for drug research and development. Nat. Rev. Drug Discov. 20, 881–882 (2021).10.1038/d41573-021-00115-6 ↗
44. Vetvik, K. G. & MacGregor, E. A. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 16, 76–87 (2017).10.1016/S1474-4422(16)30293-9 ↗
45. Golden, L. C. & Voskuhl, R. The importance of studying sex differences in disease: the example of multiple sclerosis. J. Neurosci. Res. 95, 633–643 (2017).10.1002/jnr.23955 ↗
46. Bangasser, D. A. & Cuarenta, A. Sex differences in anxiety and depression: circuits and mechanisms. Nat. Rev. Neurosci. 22, 674–684 (2021).10.1038/s41583-021-00513-0 ↗
47. Meoni, S., Macerollo, A. & Moro, E. Sex differences in movement disorders. Nat. Rev. Neurol. 16, 84–96 (2020).10.1038/s41582-019-0294-x ↗
48. Barth, C., Blokland, G. A. M. & Riecher-Rössler, A. Editorial: sex and the suffering brain — a call for sex-stratified analyses in psychiatric research. Front. Psychiatry 13, 849009 (2022).10.3389/fpsyt.2022.849009 ↗
49. Laws, K. R., Irvine, K. & Gale, T. M. Sex differences in cognitive impairment in Alzheimer’s disease. World J. Psychiatry 6, 54 (2016).10.5498/wjp.v6.i1.54 ↗
50. Castro-Aldrete, L. et al. Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution. Front. Aging Neurosci. 15, 1105620 (2023).10.3389/fnagi.2023.1105620 ↗
51. Hampel, H. et al. Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification. Front. Neuroendocrinol. 50, 31–51 (2018).10.1016/j.yfrne.2018.06.001 ↗
52. Martinkova, J. et al. Proportion of women and reporting of outcomes by sex in clinical trials for Alzheimer disease. JAMA Netw. Open 4, e2124124 (2021).10.1001/jamanetworkopen.2021.24124 ↗
53. Brand, B. A. et al. Antipsychotic medication for women with schizophrenia spectrum disorders. Psychol. Med. 52, 649–663 (2022).10.1017/S0033291721004591 ↗
54. Cerri, S., Mus, L. & Blandini, F. Parkinson’s disease in women and men: what’s the difference? J. Parkinsons Dis. 9, 501–515 (2019).10.3233/JPD-191683 ↗
55. Gilmer, G. et al. Female aging: when translational models don’t translate. Nat. Aging 3, 1500–1508 (2023).10.1038/s43587-023-00509-8 ↗
56. Roh, D., Chang, J.-G., Yoon, S. & Kim, C.-H. Antipsychotic prescribing patterns in first-episode schizophrenia: a five-year comparison. Clin. Psychopharmacol. Neurosci. 13, 275–282 (2015).10.9758/cpn.2015.13.3.275 ↗
57. US Food and Drug Administration. Drug approval package: Zyprexa intramuscular (olanzapine) injection. FDA https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21253_Zyprexa.TOC.cfm (2004).
58. Stamoula, E., Stamatellos, V.-P., Vavilis, T., Dardalas, I. & Papazisis, G. Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System Database (FAERS). Expert Opin. Drug Saf. 23, 239–245 (2024).10.1080/14740338.2023.2248873 ↗
59. Keating, D. et al. Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode. BMJ Open 7, e013881 (2017).10.1136/bmjopen-2016-013881 ↗
60. Castellani, L. et al. Preclinical and clinical sex differences in antipsychotic-induced metabolic disturbances: a narrative review of adiposity and glucose metabolism. J. Psychiatr. Brain Sci. https://doi.org/10.20900/jpbs.20190013 (2019).10.20900/jpbs.20190013 ↗
61. Yokoyama, M., Kobayashi, H., Tatsumi, L. & Tomita, T. Mouse models of Alzheimer’s disease. Front. Mol. Neurosci. 15, 1171–1183 (2022).10.3389/fnmol.2022.912995 ↗
62. Drummond, E. & Wisniewski, T. Alzheimer’s disease: experimental models and reality. Acta Neuropathol. 133, 155–175 (2017).10.1007/s00401-016-1662-x ↗
63. Blaikie, L., Kay, G., Maciel, P. & Kong Thoo Lin, P. Experimental modelling of Alzheimer’s disease for therapeutic screening. Eur. J. Med. Chem. Rep. 5, 100044 (2022).
64. Lancaster, M. A. & Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125 (2014).10.1126/science.1247125 ↗
65. Nawroth, J., Rogal, J., Weiss, M., Brucker, S. Y. & Loskill, P. Organ-on-a-chip systems for women’s health applications. Adv. Healthc. Mater. 7, 1700550 (2018).10.1002/adhm.201700550 ↗
66. Clayton, J. A. Applying the new SABV (sex as a biological variable) policy to research and clinical care. Physiol. Behav. 187, 2–5 (2018).10.1016/j.physbeh.2017.08.012 ↗
67. European Commission: Directorate-General for Research and Innovation. Gendered innovations 2: how inclusive analysis contributes to research and innovation (Publications Office of the European Union, 2020).
68. Heidari, S., Babor, T. F., De Castro, P., Tort, S. & Curno, M. Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res. Integr. Peer Rev. 1, 2 (2016).10.1186/s41073-016-0007-6 ↗
69. Rechlin, R. K., Splinter, T. F. L., Hodges, T. E., Albert, A. Y. & Galea, L. A. M. An analysis of neuroscience and psychiatry papers published from 2009 and 2019 outlines opportunities for increasing discovery of sex differences. Nat. Commun. 13, 2137 (2022).10.1038/s41467-022-29903-3 ↗
70. Guo, D., Zhang, L., Wang, X., Zheng, J. & Lin, S. Establishment methods and research progress of livestock and poultry immortalized cell lines: a review. Front. Vet. Sci. 9, 956357 (2022).10.3389/fvets.2022.956357 ↗
71. Buoncervello, M. et al. Preclinical models in the study of sex differences. Clin. Sci. 131, 449–469 (2017).10.1042/CS20160847 ↗
72. Chebib, J., Jackson, B. C., López-Cortegano, E., Tautz, D. & Keightley, P. D. Inbred lab mice are not isogenic: genetic variation within inbred strains used to infer the mutation rate per nucleotide site. Heredity 126, 107–116 (2021).10.1038/s41437-020-00361-1 ↗
73. Balon, K. & Wiatrak, B. PC12 and THP-1 cell lines as neuronal and microglia model in neurobiological research. Appl. Sci. 11, 3729 (2021).10.3390/app11093729 ↗
74. Fontana, I. C. et al. Amyloid‐β oligomers in cellular models of Alzheimer’s disease. J. Neurochem. 155, 348–369 (2020).10.1111/jnc.15030 ↗
75. Dubey, S. K. et al. Recent expansions on cellular models to uncover the scientific barriers towards drug development for Alzheimer’s disease. Cell Mol. Neurobiol. 39, 181–209 (2019).10.1007/s10571-019-00653-z ↗
76. Lund, M. E., To, J., O’Brien, B. A. & Donnelly, S. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus. J. Immunol. Methods 430, 64–70 (2016).10.1016/j.jim.2016.01.012 ↗
77. Crowe, A. et al. Compound screening in cell-based models of tau inclusion formation: comparison of primary neuron and HEK293 cell assays. J. Biol. Chem. 295, 4001–4013 (2020).10.1074/jbc.RA119.010532 ↗
78. Honarnejad, K. et al. Development and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer’s disease. PLoS ONE 8, e80645 (2013).10.1371/journal.pone.0080645 ↗
79. Honarnejad, K. et al. FRET-based calcium imaging: a tool for high-throughput/content phenotypic drug screening in Alzheimer disease. SLAS Discov. 18, 1309–1320 (2013).10.1177/1087057113502672 ↗
80. Bloem, B. R., Okun, M. S. & Klein, C. Parkinson’s disease. Lancet 397, 2284–2303 (2021).10.1016/S0140-6736(21)00218-X ↗
81. Holmes, S., Singh, M., Su, C. & Cunningham, R. L. Effects of oxidative stress and testosterone on pro-inflammatory signaling in a female rat dopaminergic neuronal cell line. Endocrinology 157, 2824–2835 (2016).10.1210/en.2015-1738 ↗
82. Cetin, S., Knez, D., Gobec, S., Kos, J. & Pišlar, A. Cell models for Alzheimer’s and Parkinson’s disease: at the interface of biology and drug discovery. Biomed. Pharmacother. 149, 112924 (2022).10.1016/j.biopha.2022.112924 ↗
83. Ferrari, E., Cardinale, A., Picconi, B. & Gardoni, F. From cell lines to pluripotent stem cells for modelling Parkinson’s disease. J. Neurosci. Methods 340, 108741 (2020).10.1016/j.jneumeth.2020.108741 ↗
84. Geraghty, R. J. et al. Guidelines for the use of cell lines in biomedical research. Br. J. Cancer 111, 1021–1046 (2014).10.1038/bjc.2014.166 ↗
85. Lopes-Ramos, C. M. et al. Sex differences in gene expression and regulatory networks across 29 human tissues. Cell Rep. 31, 107795 (2020).10.1016/j.celrep.2020.107795 ↗
86. O’Connor, C. Chromosomal abnormalities: aneuploidies. Nat. Educ. 1, 172 (2008).
87. Xu, J. et al. Free-living human cells reconfigure their chromosomes in the evolution back to uni-cellularity. eLife 6, e28070 (2017).10.7554/eLife.28070 ↗
88. Holland, A. & Bradbury, N. A. Did you forget your cell sex? An update on the inclusion of sex as a variable in AJP-Cell Physiology. Am. J. Physiol. Cell Physiol. 324, C910–C926 (2023).10.1152/ajpcell.00434.2022 ↗
89. Baker, D. et al. Detecting genetic mosaicism in cultures of human pluripotent stem cells. Stem Cell Rep. 7, 998–1012 (2016).10.1016/j.stemcr.2016.10.003 ↗
90. Assou, S. et al. Recurrent genetic abnormalities in human pluripotent stem cells: definition and routine detection in culture supernatant by targeted droplet digital PCR. Stem Cell Rep. 14, 1–8 (2020).10.1016/j.stemcr.2019.12.004 ↗
91. Hergenhahn, L. et al. Cytogenomic characterization of murine neuroblastoma cell line neuro-2a and its two derivatives neuro-2a TR-alpha and neuro-2a TR-beta. Cells 13, 1889 (2024).10.3390/cells13221889 ↗
92. Binz, R. L. et al. Identification of novel breakpoints for locus- and region-specific translocations in 293 cells by molecular cytogenetics before and after irradiation. Sci. Rep. 9, 10554 (2019).10.1038/s41598-019-47002-0 ↗
93. Rouillard, A. D. et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database 2016, baw100 (2016).10.1093/database/baw100 ↗
94. Xicoy, H., Wieringa, B. & Martens, G. J. M. The SH-SY5Y cell line in Parkinson’s disease research: a systematic review. Mol. Neurodegener. 12, 10 (2017).10.1186/s13024-017-0149-0 ↗
95. Richter, M. et al. From donor to the lab: a fascinating journey of primary cell lines. Front. Cell Dev. Biol. 9, 711381 (2021).10.3389/fcell.2021.711381 ↗
96. Harper, J. M. Primary cell culture as a model system for evolutionary molecular physiology. Int. J. Mol. Sci. 25, 7905 (2024).10.3390/ijms25147905 ↗
97. Bradford, A. B. & McNutt, P. M. Importance of being Nernst: synaptic activity and functional relevance in stem cell-derived neurons. World J. Stem Cell 7, 899–921 (2015).10.4252/wjsc.v7.i6.899 ↗
98. Sun, Z., Williams, D. J., Xu, B. & Gogos, J. A. Altered function and maturation of primary cortical neurons from a 22q11.2 deletion mouse model of schizophrenia. Transl. Psychiatry 8, 85 (2018).10.1038/s41398-018-0132-8 ↗
99. Baldassarro, V. A., Marchesini, A., Giardino, L. & Calzà, L. Vulnerability to oxygen-glucose deprivation of primary neurons derived from Tg2576 Alzheimer mice: role of intraneuronal Abeta accumulation and astrocytes. Dis. Model. Mech. https://doi.org/10.1242/dmm.028001 (2017).10.1242/dmm.028001 ↗
100. Li, S., Roy, E. R., Wang, Y., Watkins, T. & Cao, W. Modeling Alzheimer’s disease in primary neurons reveals DNA damage response coupled with MAPK-DLK signaling in wild-type tau-induced neurodegeneration. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-2617457/v1 (2023).10.21203/rs.3.rs-2617457/v1 ↗